Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract A5: microRNA response to hypoxic stress in soft tissue sarcoma cells

Caroline M.M. Gits, Jonneke C.W.M. de Rijck, Patricia F. van Kuijk, Moniek B.E. Jonkers, Jaap Verweij, Stefan Sleijfer, Erik A.C. Wiemer

Cancer Res (2011) 71 (18_Supplement): A5.

https://doi.org/10.1158/1538-7445.FBCR11-A5

Published: 28 October 2014

View article titled, Abstract A5: microRNA response to hypoxic stress in soft tissue sarcoma cells

Journal Articles

Abstract 1450: MicroRNAs in myxoid/round cell liposarcomas: FUS-CHOP regulated miR-497 and miR-30a target the insulin-like growth factor receptor pathway

Caroline M. Gits, Patricia F. van Kuijk, Wilfred F. van IJcken, Ron HJ Mathijssen, Michael A. den Bakker, Jaap Verweij, Stefan Sleijfer, Erik AC Wiemer

Cancer Res (2014) 74 (19_Supplement): 1450.

https://doi.org/10.1158/1538-7445.AM2014-1450

Published: 01 October 2014

View article titled, Abstract 1450: MicroRNAs in myxoid/round cell liposarcomas: FUS-CHOP regulated miR-497 and miR-30a target the insulin-like growth factor receptor pathway

Journal Articles

Abstract 949: miR-634 restores drug sensitivity in tumor cells derived from patients with terminal drug-resistant ovarian cancer.

Marijn TM van Jaarsveld, Patricia F. van Kuijk, Antonius WM Boersma, Jozien Helleman, Wilfred F. van Ijcken, Ron HJ Mathijssen, Joris Pothof, Els MJJ Berns, Jaap Verweij, Erik AC Wiemer

Cancer Res (2013) 73 (8_Supplement): 949.

https://doi.org/10.1158/1538-7445.AM2013-949

Published: 15 April 2013

View article titled, Abstract 949: miR-634 restores drug sensitivity in tumor cells derived from patients with terminal drug-resistant ovarian cancer.

Journal Articles

Abstract 883: Imatinib-induced modulation of gastrointestinal and hepatic membrane transporters in mice.

Herman Burger, Alexander T. den Dekker, Antonius WM Boersma, Peter de Bruijn, Jaap Verweij, Ron HJ Mathijssen, Erik AC Wiemer

Cancer Res (2013) 73 (8_Supplement): 883.

https://doi.org/10.1158/1538-7445.AM2013-883

Published: 15 April 2013

View article titled, Abstract 883: Imatinib-induced modulation of gastrointestinal and hepatic membrane transporters in mice.

Journal Articles

Abstract 4952: Functional characterization of microRNAs associated with the response to cisplatin of ovarian cancer cells

Marijn T. van Jaarsveld, Maikel D. Wouters, Antonius W. Boersma, Patricia F. van Kuijk, Jaap Verweij, Joris Pothof, Erik A. Wiemer

Cancer Res (2011) 71 (8_Supplement): 4952.

https://doi.org/10.1158/1538-7445.AM2011-4952

Published: 15 April 2011

View article titled, Abstract 4952: Functional characterization of microRNAs associated with the response to cisplatin of ovarian cancer cells

Journal Articles

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, Catherine Sebban, Axel Le Cesne, Ian Judson, Olivier Tredan, Jaap Verweij, Pierre Biron, Inthidar Labidi, Jean-Paul Guastalla, Thomas Bachelot, David Perol, Sylvie Chabaud, Pancras C.W. Hogendoorn, Philippe Cassier, Armelle Dufresne, Jean-Yves Blay, on behalf of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Cancer Res (2009) 69 (13): 5383–5391.

https://doi.org/10.1158/0008-5472.CAN-08-3845

Published: 01 July 2009

View article titled, Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Journal Articles

Abstract LB-201: Updated results from a Phase I study of AV-951 (KRN951), a potent and selective VEGFR-1, -2 and -3 tyrosine kinase inhibitor, in patients with advanced solid tumors

Ferry A.l.m. Eskens, Maja J.a. de Jonge, Brooke Esteves, Monette Cotreau, Pankaj Bhargava, John Ryan, Leny van Doorn, Toshiyuki Isoe, Kunihiko Hayashi, Lena Ekman, Herman Burger, Jaap Verweij

Cancer Res (2008) 68 (9_Supplement): LB-201.

https://doi.org/10.1158/1538-7445.AM2008-LB-201

Published: 15 May 2008

View article titled, Abstract LB-201: Updated results from a Phase I study of AV-951 (KRN951), a potent and selective VEGFR-1, -2 and -3 tyrosine kinase inhibitor, in patients with advanced solid tumors

Journal Articles

Updated results from a Phase I study of AV-951 (KRN951), a potent and selective VEGFR-1, -2 and -3 tyrosine kinase inhibitor, in patients with advanced solid tumors

Ferry Eskens, Maja de Jonge, Brooke Esteves, Monette Cotreau, Pankaj Bhargava, John Ryan, Leny van Doorn, Toshiyuki Isoe, Kunihiko Hayashi, Lena Ekman, Herman Burger, Jaap Verweij

Cancer Res (2008) 68 (9_Supplement): LB-201.

Published: 01 May 2008

View article titled, Updated results from a Phase I study of AV-951 (KRN951), a potent and selective VEGFR-1, -2 and -3 tyrosine kinase inhibitor, in patients with advanced solid tumors

Journal Articles

Interaction of platinum compounds with the human organic cation transporter hOCT2 (SLC22A2)

Herman Burger, Adja Zoumaro-Djayoon, Antonius Boersma, Walter Loos, Jaap Verweij, Kees Nooter, Eric Wiemer

Cancer Res (2008) 68 (9_Supplement): 698.

Published: 01 May 2008

View article titled, Interaction of platinum compounds with the human organic cation transporter hOCT2 (SLC22A2)

Journal Articles

Aurora B kinase related biomarker modulation by PHA-739358: translation of preclinical studies into clinical phase I trials

Patrizia Carpinelli, Roberta Ceruti, Valter Croci, Enrico Pesenti, Riccardo Spinelli, Maja De Jonge, Jaap Verweij, Hans Gelderblom, Howard A. Burris, Roger Cohen, Daniele Fancelli, Jurgen Moll

Cancer Res (2007) 67 (9_Supplement): 1818.

Published: 01 May 2007

View article titled, Aurora B kinase related biomarker modulation by PHA-739358: translation of preclinical studies into clinical phase I trials

Journal Articles

Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11)

Floris A. De Jong, Frederike E. Engels, Alex Sparreboom, Walter J. Loos, Peter De Bruijn, Lena E. Friberg, Ron A. Mathôt, Jaap Verweij, Ron H. Mathijssen

Cancer Res (2005) 65 (9_Supplement): 938–939.

Published: 01 May 2005

View article titled, Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11)

Journal Articles

Impact of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

Erin R. Lepper, Sharyn D. Baker, Matthew Permenter, Nicole Ries, Ron H. Van Schaik, Paul W. Schenk, Douglas K. Price, Danielle Ahn, Nicola F. Smith, George Cusatis, Roxanne G. Ingersoll, Susan E. Bates, Ron H. Mathijssen, Jaap Verweij, William D. Figg, Alex Sparreboom

Cancer Res (2005) 65 (9_Supplement): 980.

Published: 01 May 2005

View article titled, Impact of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

Journal Articles

How do we define success or failure of a targeted therapy?

Jaap Verweij

Cancer Res (2004) 64 (7_Supplement): 1321.

Published: 01 April 2004

View article titled, How do we define success or failure of a targeted therapy?

Journal Articles

Prospective validation of a limited sampling model predicting SN-38 pharmacokinetics

Floris A. De Jong, Ron H. Mathijssen, Peter De Bruijn, Edwin W. Willems, Jaap Verweij, Alex Sparreboom

Cancer Res (2004) 64 (7_Supplement): 1095.

Published: 01 April 2004

View article titled, Prospective validation of a limited sampling model predicting SN-38 pharmacokinetics

Journal Articles

Effect of the ABCG2 421C>A polymorphism on irinotecan pharmacokinetics

Ron H. Mathijssen, Sharon Marsh, Floris A. De Jong, Mats O. Karlsson, Cristi King, Jaap Verweij, Alex Sparreboom, Howard L. McLeod

Cancer Res (2004) 64 (7_Supplement): 1095.

Published: 01 April 2004

View article titled, Effect of the ABCG2 421C>A polymorphism on irinotecan pharmacokinetics

Journal Articles

Analysis of c-kit exon 11 and PDGFR exon 12 and 18 activating mutations in human cancer

Herman Burger, Michael A. Den Bakker, Hans Van Tol, Maria Debiec-Rychter, Gerrit Stoter, Jaap Verweij, Kees Nooter

Cancer Res (2004) 64 (7_Supplement): 624.

Published: 01 April 2004

View article titled, Analysis of c-kit exon 11 and PDGFR exon 12 and 18 activating mutations in human cancer

Journal Articles

Cremophor EL-mediated Alteration of Paclitaxel Distribution in Human Blood: Clinical Pharmacokinetic Implications

Alex Sparreboom, Lia van Zuylen, Eric Brouwer, Walter J. Loos, Peter de Bruijn, Hans Gelderblom, Marrimuthoo Pillay, Kees Nooter, Gerrit Stoter, Jaap Verweij

Cancer Res (1999) 59 (7): 1454–1457.

Published: 01 April 1999

View article titled, Cremophor EL-mediated Alteration of Paclitaxel Distribution in Human Blood: <subtitle>Clinical Pharmacokinetic Implications</subtitle>

Journal Articles

Radioimmunodetection in Rhabdo- and Leiomyosarcoma with ¹¹¹In-Anti-Myosin Monoclonal Antibody Complex

André Planting, Jaap Verweij, Peter Cox, Mike Pillay, Gerrit Stoter

Cancer Res (1990) 50 (3_Supplement): 955s–957s.

Published: 01 February 1990

View article titled, Radioimmunodetection in Rhabdo- and Leiomyosarcoma with 111In-Anti-Myosin Monoclonal Antibody Complex

NARROW

Abstract A5: microRNA response to hypoxic stress in soft tissue sarcoma cells

Abstract 1450: MicroRNAs in myxoid/round cell liposarcomas: FUS-CHOP regulated miR-497 and miR-30a target the insulin-like growth factor receptor pathway

Abstract 949: miR-634 restores drug sensitivity in tumor cells derived from patients with terminal drug-resistant ovarian cancer.

Abstract 883: Imatinib-induced modulation of gastrointestinal and hepatic membrane transporters in mice.

Abstract 4952: Functional characterization of microRNAs associated with the response to cisplatin of ovarian cancer cells

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Abstract LB-201: Updated results from a Phase I study of AV-951 (KRN951), a potent and selective VEGFR-1, -2 and -3 tyrosine kinase inhibitor, in patients with advanced solid tumors

Updated results from a Phase I study of AV-951 (KRN951), a potent and selective VEGFR-1, -2 and -3 tyrosine kinase inhibitor, in patients with advanced solid tumors

Interaction of platinum compounds with the human organic cation transporter hOCT2 (SLC22A2)

Aurora B kinase related biomarker modulation by PHA-739358: translation of preclinical studies into clinical phase I trials

Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11)

Impact of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

How do we define success or failure of a targeted therapy?

Prospective validation of a limited sampling model predicting SN-38 pharmacokinetics

Effect of the ABCG2 421C>A polymorphism on irinotecan pharmacokinetics

Analysis of c-kit exon 11 and PDGFR exon 12 and 18 activating mutations in human cancer

Cremophor EL-mediated Alteration of Paclitaxel Distribution in Human Blood: Clinical Pharmacokinetic Implications

Radioimmunodetection in Rhabdo- and Leiomyosarcoma with ¹¹¹In-Anti-Myosin Monoclonal Antibody Complex

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only